Ligand validation:4BN4

AR6: [(2R,3S,4R,5R)-5-(6-AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL [HYDROXY-[[(2R,3S,4R,5S)-3,4,5-TRIHYDROXYOXOLAN-2-YL]METHOXY]PHOSPHORYL] HYDROGEN PHOSPHATE

AR6 is a Ligand Of Interest in 4BN4 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4BN4_AR6_A_1395	100%	36%	0.05	0.993	1.15	1.36	3	4	1	0	100%	1
4BVB_AR6_A_1396	95%	19%	0.077	0.982	1.26	2.18	3	11	0	0	100%	1
4BVH_AR6_B_1393	93%	26%	0.086	0.979	1.1	1.85	2	10	2	0	100%	1
7TX0_AR6_A_201	100%	19%	0.04	0.995	2.27	1.23	9	2	0	0	100%	0.954
7TWW_AR6_A_201	100%	25%	0.043	0.996	1.88	1.17	6	2	0	0	100%	0.988
7TWX_AR6_A_201	100%	20%	0.044	0.995	2.15	1.23	8	2	0	0	100%	0.953
7TWV_AR6_A_201	100%	23%	0.048	0.996	1.98	1.23	6	2	0	0	100%	0.983
7TX1_AR6_A_201	100%	17%	0.046	0.994	2.39	1.23	10	2	0	0	100%	0.954

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.